Nanfang Hospital, Southern Medical University: End Stage Liver Disease trials
The registry lists 10 End Stage Liver Disease studies with Nanfang Hospital, Southern Medical University as lead sponsor. 2 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter StudyNot yet recruitingNCT06377774
- SSM Predicts Outcomes of CLD Inpatients With Acute Liver InjuryRecruitingNCT06173947
- Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on-chronic Liver FailureStatus unknownNCT04747106Not applicable
- Platelet Transfusion in Acute-on Chronic Liver FailureStatus unknownNCT04564651Not applicable
- Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver DiseasesStatus unknownNCT04125654Not applicable
- A Multicenter Prospective Study of Application of Platelet Mapping in Acute-on-chronic-liver Failure in ChinaCompletedNCT04119973
- Platelet Transfusion in HBV-related acute-on Chronic Liver FailureStatus unknownNCT03713489Not applicable
- A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in ChinaCompletedNCT03281278
- A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in ChinaCompletedNCT03281265
- A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in ChinaStatus unknownNCT03281252